Pear Therapeutic files for bankrupcy
Pear Therapeutics, Inc. a company focused on developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced that the Company and its wholly owned subsidiary, Pear Therapeutics (US), Inc. (collectively, the “Debtors”) each voluntarily filed for protection under chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware and they intend to pursue a sale of the business or assets under section 363 of the Bankruptcy Code